相关实验视频

Updated: Jan 13, 2026

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

在临床前胰腺癌治疗中利用LIFE生物材料和光子闪光的免疫反应

Michele Moreau¹, Katelyn Kelly¹, Serena Mao¹

¹Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, MD 21287, USA.

|October 29, 2025

概括

与LIFE生物材料相结合的超高剂量速率闪光放射疗法 (Flash-RT) 对胰腺癌显示有前途. 这种组合增强了T细胞透,并在临床前模型中改善了生存率.

科学领域:

在瘤学瘤学.
辐射瘤学辐射瘤学
免疫治疗是一种免疫疗法.

背景情况:

超高剂量速率 (≥40 Gy/s) 闪光放射疗法 (Flash-RT) 节省正常组织,同时保持抗瘤作用.
胰腺癌需要新的治疗策略来改善患者的治疗结果.
将Flash-RT与免疫原生物材料相结合可能会提高治疗比率.

研究的目的:

评估闪光放射治疗 (Flash-RT) 和LIFE生物材料与抗小鼠CD40单克隆抗体的组合.
在临床前模型中提高胰腺癌治疗的治疗比率.
为了研究组合疗法引起的免疫反应.

主要方法:

在C57BL6小鼠中产生了同源性皮下胰腺瘤.
瘤被用超高剂量速率 (闪电SARRP) 或常规 (CONV) 放射治疗以不同剂量 (5-15 Gy) 治疗.
评估了瘤生长,存活率和T细胞透率 (通过多重免疫光和免疫组织化学).

主要成果:

与对照组相比,Flash-RT和CONV放射治疗都表现出类似的瘤控制能力.
与CONV和对照组相比,FLASH组在5Gy时的生存时间明显更长.
使用RT (FLASH或CONV) 和LIFE生物材料的联合治疗增加了瘤中T细胞透率.

结论:

闪光RT和LIFE生物材料的组合值得进一步研究胰腺癌治疗.
利用免疫反应是一个有希望的策略,以提高闪光RT的疗效.
这项临床前研究为未来的胰腺癌临床试验提供了理由.

关键词:

生命生物材料生物材料免疫反应的免疫反应.免疫组织化学免疫组织化学辐射疗法辐射疗法超高剂量速率 (≥40 Gy/s) 闪光灯

更多相关视频

Bioluminescent Orthotopic Model of Pancreatic Cancer Progression

Bioluminescent Orthotopic Model of Pancreatic Cancer Progression

Published on: June 28, 2013

Fluorescent Orthotopic Mouse Model of Pancreatic Cancer

Fluorescent Orthotopic Mouse Model of Pancreatic Cancer

Published on: September 20, 2016

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.